Evidence map›Paper›PMID 25455992›Full record

SynthesisThe Lancet. Infectious diseases2014

Global, regional, and national estimates of pneumonia burden in HIV-infected children in 2010: a meta-analysis and modelling study.

Evropi Theodoratou, David A McAllister, Craig Reed, Davies O Adeloye, Igor Rudan, Lulu M Muhe, Shabir A Madhi, Harry Campbell, Harish Nair

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Lancet. Infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 6 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 6 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Observational
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Evropi TheodoratouCentre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
David A McAllisterCentre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
Craig ReedCentre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
Davies O AdeloyeCentre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
Igor RudanCentre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
Lulu M MuheDepartment of Maternal, Newborn, Child and Adolescent Health, WHO, Geneva, Switzerland.
Shabir A MadhiCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Sandringham, South Africa; Respiratory and Meningeal Pathogens Research Unit, Medical Research Council, University of Witwatersrand, Witwatersrand, South Africa; Department of Science and Technology, University of Witwatersrand, Witwatersrand, South Africa; Vaccine Preventable Diseases, National Research Foundation, University of Witwatersrand, Witwatersrand, South Africa.
Harry CampbellCentre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
Harish NairCentre for Population Health Sciences, University of Edinburgh, Edinburgh, UK; Public Health Foundation of India, New Delhi, India. Electronic address: harish.nair@ed.ac.uk.
University of Edinburgh · GBUniversity of the Witwatersrand · ZA

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundGlobally, pneumonia is a leading cause of mortality and morbidity in children younger than 5 years. Underlying HIV infection is an important risk factor for pneumonia morbidity and mortality in children. There are, however, no global or country level estimates of pneumonia burden in HIV-infected children. We assessed the role of HIV in pneumonia incidence and mortality and estimated the number of pneumonia cases and deaths in HIV-infected children younger than 5 years in 133 high pneumonia-burden countries in 2010.

methodsWe estimated the risk of hospital admission and case fatality rate caused by pneumonia in HIV-infected children compared with HIV-uninfected children from a systematic review of studies published in Medline, Embase, and Global Health between Jan 1, 1980, and Aug 31, 2013. We estimated nationwide pneumonia incidence and mortality with two different models that incorporated several risk factors for paediatric pneumonia hospital admission and mortality (including HIV infection). We then estimated the number of pneumonia episodes and deaths that occurred in HIV-infected children in 2010.

findingsThe odds ratio (OR) for hospital admission for all-cause pneumonia in HIV-infected children compared with HIV-uninfected children was 6·5 (95% CI 5·9-7·2). The risk of death was higher in children with pneumonia and HIV compared with those with pneumonia only (OR 5·9, 95% CI 2·7-12·7). In 2010, 1·4 million pneumonia episodes (uncertainty range [UR] 0·6 million to 3·3 million) and 88 000 pneumonia deaths (UR 47 400-153 000) occurred in HIV-infected children in low-income countries. Of these, 1·2 million pneumonia episodes (UR 0·5 million-2·7 million) and 85 400 deaths (UR 46 000-147 300) were directly attributable to HIV. 1·3 million (90%) pneumonia episodes and 82 400 (93%) pneumonia deaths in HIV-infected children aged younger than 5 years occurred in the WHO African region.

interpretationGlobally, a small proportion of pneumonia episodes and pneumonia deaths occur in HIV-infected children. However, in the highest HIV-burden countries in sub-Saharan Africa (ie, Swaziland, Lesotho, and Zimbabwe) up to a fifth of all pneumonia cases and 60% of pneumonia deaths occur in HIV-infected children. In these countries, major reductions in child pneumonia mortality can be achieved only if the systemic challenges plaguing the health system (poor coverage of early infant testing for HIV, of antiretroviral drugs in pregnant women and young children, of co-trimoxazole prophylaxis, and of pneumococcal vaccination) can be overcome.

fundingWHO.

Indexed as

Child, PreschoolFemaleGlobal HealthHIV InfectionsHospitalizationHumansIncidenceInfantInfant, NewbornMaleMortalityPneumoniaSurvival Analysis

Identifiers

PMID25455992
PMCPMC4242006
OpenAlexW2119314112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.